Skip to main content

Table 2 Varicella vaccinations <17 years of age in Munich paediatric practices during five consecutive varicella seasons; absolute numbers and mean number per 1000 patient contacts (with 95% confidence interval, CI)

From: Varicella routine vaccination and the effects on varicella epidemiology – results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011

Season

1

2

3

4

5

1-5

Surveillance period

Oct 06-Sep 07

Oct 07-Sep 08

Oct 08-Sep 09

Oct 09-Sep 10

Oct 10-Sep 11

Oct 06-Sep 11

(N all monthly reports)

(N = 1015)

(N = 965)

(N = 1013)

(N = 974)

(N = 947)

(N = 4914)

Varicella vaccinations - all; 1st dose

      

- n

8234

9928

11872

10247

9768

50049

- mean per 1000 patient contacts (95%CI)

9.53 (9.03-10.03)

11.52 (10.96-12.09)

13.96 (13.30-14.63)

12.98 (12.32-13.65)

12.86 (12.25-13.48)

12.17 (11.89-12.44)

Varicella vaccinations - all; 2nd dose

      

- n

809

1703

13292

12967

11770

40541

- mean per 1000 patient contacts (95%CI)

0.98 (0.85-1.12)

2.17 (1.92-2.43)

15.12 (14.08-16.16)

15.68 (14.89-16.48)

14.76 (14.07-15.44)

9.72 (9.36-10.07)

Varicella vaccinations - monovalent; 1st dose

      

- n

6799

8289

3985

2095

1349

22517

- mean per 1000 patient contacts (95%CI)

7.73 (7.31-8.15)

9.43 (8.91-9.95)

4.32 (3.95-4.68)

2.71 (2.41-3.02)

1.93 (1.71-2.16)

5.25 (5.06-5.44)

Varicella vaccinations - monovalent; 2nd dose

      

- n

131

425

7524

5747

3553

17380

- mean per 1000 patient contacts (95%CI)

0.18 (0.12-0.24)

0.59 (0.42-0.75)

8.30 (7.52-9.08)

6.86 (6.35-7.37)

4.46 (4.13-4.78)

4.09 (3.86-4.31)

Varicella vaccinations - MMR-V; 1st dose

      

- n

1435

1639

7887

8152

8419

27532

- mean per 1000 patient contacts (95%CI)

1.80 (1.60-2.00)

2.10 (1.88-2.31)

9.66 (9.12-10.20)

10.30 (9.74-10.85)

10.95 (10.40-11.51)

6.93 (6.70-7.16)

Varicella vaccinations - MMR-V; 2nd dose

      

- n

678

1278

5768

7220

8217

23161

- mean per 1000 patient contacts (95%CI)

0.80 (0.69-0.92)

1.59 (1.41-1.76)

6.84 (5.90-7.31)

8.86 (8.36-9.37)

10.30 (9.77-10.83)

5.64 (5.43-5.84)

  1. Data from BaVariPro Practice Surveillance; Oct 2006-Sep 2011.
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us